Merit Medical to Participate at Six Upcoming Conferences

NEXT STORY
DBV Technologies Announces Publication of Detailed Phase III Trial Results Evaluating Viaskin Peanut as a Novel Treatment for Peanut Allergy in The Journal of the American Medical Association
PREV STORY
Trillium Announces Pricing of US$15 Million Public Offering of Common Share Units and Series II Non-Voting Convertible First Preferred Share Units
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Yamana Gold Releases Its Greenhouse Gas Abatement Targets Consistent With a 1.5ºC Science-Based Temperature Scenario

author_avatar
NASDAQ Market News

Chi-Med Highlights Clinical Data to be Presented at the Upcoming ESMO Virtual Congress 2020

author_avatar
NASDAQ Market News

Onxeo Reports Full-Year 2020 Financial Results and Provides Business Update

author_avatar
NASDAQ Market News